CIK: 0001538653 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $1,231,170 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CACC | CREDIT ACCEP CORP MICH | 1,560,014 | $740,071 | 60.1% | $107.75 | +325.8% | COM | 225310101 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $134,352 | 10.9% | $81.92 | -3.6% | COM | 981419104 |
| W | WAYFAIR INC | 3,823,239 | $125,746 | 10.2% | $53.95 | -35.3% | CL A | 94419L101 |
| CMPR | CIMPRESS PLC | 3,906,492 | $107,858 | 8.8% | $129.96 | -80.0% | SHS EURO | G2143T103 |
| YELP | YELP INC | 2,524,750 | $69,027 | 5.6% | $30.67 | +3.4% | CL A | 985817105 |
| GIC | GLOBAL INDUSTRIAL COMPANY | 1,279,677 | $30,111 | 2.4% | $32.63 | -27.9% | COM | 37892E102 |
| GRND | GRINDR INC | 4,416,557 | $20,537 | 1.7% | $9.29 | 0.0% | COM | 39854F101 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 1,851,851 | $2,167 | 0.2% | $1.03 | +22.3% | COM | 53566P109 |
| HUMA | HUMACYTE INC | 568,246 | $1,199 | 0.1% | $6.34 | -52.1% | COM | 44486Q103 |
| — | AGEX THEREPEUTICS INC | 185,185 | $102 | 0.0% | $2.99 | — | COM | 00848H108 |